Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2026
Adjustable Vocal Implant System (VOIS) for Unilateral Vocal Fold Paralysis: Short-Term Outcomes From a 12-Patient Case Series.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kebbe Sam, Keane Michael, Gao Chuanyu, Devabalan Yadsan, Ho Guan-Min, Bidaye Rohan
Аннотация
BACKGROUND: Unilateral vocal cord palsy (UVCP) significantly affects phonation and swallowing. While injection laryngoplasty and medialisation thyroplasty are effective, both may require revision. Vocal Implant System (VOIS; APrevent Biotech GmbH) is an adjustable titanium-silicone thyroplasty implant that allows postoperative modification, potentially reducing the need for further surgery.
METHODS: Twelve patients, seven male and five female, underwent VOIS implantation. Voice outcomes were assessed pre- and postoperatively using the GRBAS scale and the Voice Handicap Index-10 (VHI-10).
RESULTS: The composite GRBAS score improved significantly from 9.0 ± 1.87 to 3.75 ± 2.49 (p = 0.0024). The VHI-10 decreased from 25.75 ± 9.36 to 14.92 ± 9.55 (p = 0.0093). No intra- or postoperative complications occurred. Two patients required postoperative implant volume adjustments-one performed in clinic and one under local anaesthetic in theatre.
CONCLUSION: The VOIS implant thyroplasty demonstrated significant improvement in both perceptual and patient-reported voice outcomes with a favourable safety profile. Larger, long-term studies are warranted to confirm its comparative efficacy and durability.
METHODS: Twelve patients, seven male and five female, underwent VOIS implantation. Voice outcomes were assessed pre- and postoperatively using the GRBAS scale and the Voice Handicap Index-10 (VHI-10).
RESULTS: The composite GRBAS score improved significantly from 9.0 ± 1.87 to 3.75 ± 2.49 (p = 0.0024). The VHI-10 decreased from 25.75 ± 9.36 to 14.92 ± 9.55 (p = 0.0093). No intra- or postoperative complications occurred. Two patients required postoperative implant volume adjustments-one performed in clinic and one under local anaesthetic in theatre.
CONCLUSION: The VOIS implant thyroplasty demonstrated significant improvement in both perceptual and patient-reported voice outcomes with a favourable safety profile. Larger, long-term studies are warranted to confirm its comparative efficacy and durability.